CClinicalTrials.gg
CompletedNCT06730789Updated Dec 12, 2024

Conservative Treatment in Lateral Epicondylitis

An interventional study of Epicondylitis bandage and Wrist dorsiflexion splint in Lateral Epicondylitis, sponsored by Uludag University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-12.

Sponsored by Uludag University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 11 months after the study started (first participant enrolled Dec 2020, registered Dec 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Conservative treatments follow the vast majority of treatments in lateral epicondylitis. In this research, we aimed to elucidate the treatment outcomes of patients via epicondylitis bandage, wrist dorsiflexion splint, and kinesio tape groups by sequential randomization and to compare treatment outcomes.

02

Conditions studied

  • Lateral Epicondylitis

Browse trials for

03

In context

Tennis Elbow

284 studies on the registry are indexed under Tennis Elbow; 60 are open to participants now.

This study's enrollment of 54 is close to the median of 50 across 253 interventional studies indexed under Tennis Elbow.

Browse Tennis Elbow studies →

Lead sponsor

Uludag University is the lead sponsor of 141 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who were ≥18 years of age, and had no history of elbow surgery.
  • Participants should have pain and sensitivity, with symptom duration less than 12 weeks.
  • Patients with a positive result in one of the provocation tests (Maudsley's Test-resisted middle finger extension extensor carpi radialis test), resisted wrist extension, or passive stretching of the wrist extensors (Mill's Test) were included.

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 years of age,
  • patients who did not consent to participate in the study,
  • those who had previous surgery on the elbow,
  • presence of cervical spondylosis and radiculopathy,
  • presence of endocrine disease,
  • presence of autoimmune disease,
  • presence of concomitant entrapment neuropathy or polyneuropathy,
  • pregnancy,
  • presence of systemic inflammatory disease,
  • presence of acute trauma,
  • presence of deformity in the upper extremity,
  • presence of metabolic disease,
  • presence of elbow arthritis,
  • presence of allergy to kinesio tape and orthoses,
  • having received treatment for lateral epicondylitis in the past (exercise, injection, NSAIDs).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Lateral Epicondylitis (treatment with epicondylitis bandage)

    Patients with diagnosis of lateral epicondylitis.

    Device: Epicondylitis bandage

  • Experimental
    Lateral Epicondylitis (treatment with wrist dorsiflexion orthesis)

    Patients with diagnosis of lateral epicondylitis.

    Device: Wrist dorsiflexion splint

  • Experimental
    Lateral Epicondylitis (treatment with kinesio tape)

    Patients with diagnosis of lateral epicondylitis.

    Device: Kinesio tape

Interventions

  • DeviceEpicondylitis bandage

    A conservative treatment method of lateral epicondylitis.

  • DeviceWrist dorsiflexion splint

    A conservative treatment method of lateral epicondylitis.

  • DeviceKinesio tape

    A conservative treatment method of lateral epicondylitis

06

What researchers measure

Primary outcomes

  1. Visual analog score

    Minimum value: 0 Maximum value: 10 Minimum is better.

    Time frame: Baseline

  2. Visual analog score

    Minimum value: 0 Maximum value:10 Minimum is better.

    Time frame: At sixth weeks.

Secondary outcomes

  1. Disabilities of the Arm, Shoulder Score

    Minimum value:0 Maximum value:100 Minimum is better

    Time frame: Baseline

  2. Disabilities of the Arm, Shoulder Score

    Minimum value:0 Maximum value:100 Minimum is better

    Time frame: At sixth weeks.

Other outcomes

  1. Patient-Rated Tennis Elbow Evaluation Score

    Minimum value:0 Maximum value:10 Minimum is better.

    Time frame: Baseline

  2. Patient-Rated Tennis Elbow Evaluation Score

    Minimum value:0 Maximum value:10 Minimum is better.

    Time frame: At sixth weeks.

  3. hand grip strength

    Minimum value: 0 Maximum value: 100 Maximum is better.

    Time frame: Baseline

  4. hand grip strength

    Minimum value: 0 Maximum value: 100 Maximum is better.

    Time frame: At sixth weeks.

07

Study locations

1 site
  • Bursa Uludag University
    Bursa, Nilüfer 16059, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06730789
Lead sponsor
Uludag University
Responsible party
Yücel Bilgin (MD, Orthopedics and Traumatolody Specialist, Uludag University) — Principal investigator
First posted
Dec 12, 2024
Start date
Dec 15, 2020
Primary completion
Dec 15, 2021
Completion
May 15, 2022
Last update
Dec 12, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion